This report studies the global membrane filtration market for pharmaceutical market over the forecast period of 2013 to 2018. This market is valued at an estimated $3,691.9 million in 2013 and is poised to grow at a CAGR of 16.6% from 2013 to 2018, to reach $7,960.3 million by 2018.
Membrane filtration is an important separation technique in the pharmaceutical and biotechnology industries. It finds widespread applications in the biopharmaceutical industry as biopharmaceutical products and their intermediates are susceptible to degradation due to heat and chemical treatment, which makes it difficult to separate them using alternate technologies. Membrane filtration has been used in pharmaceutical industry since 1935 and is presently one of the most widely adopted separation techniques in these industries. Based on application, the protein purification market holds the largest share in 2013. However, the sterilization market is poised to grow at the highest CAGR from 2013 to 2018.
Based on geography, the global market is segmented into North America, Europe, Asia, and Rest of the World (RoW). Europe accounts for the largest share in the membrane filtration market for pharmaceutical . The share of North America is expected to increase rapidly owing to fast growth of the pharmaceutical industry in this region.
The major players in the market are Merck Millipore (U.S.), Pall Corporation (U.S.), and Sartorius Stedim Biotech (France). Other important players in this market are 3M (U.S.) Alfa Laval (Sweden), GE (U.S.), GEA Group (Germany), Graver Technologies (U.S.), Koch Membrane Systems (U.S.), MECO (U.S.), Novasep (France), and Spectrum Laboratories (U.S.).